You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

or psoriatic arthritis (PsA).

Showing 1 - 25 of 5,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Axial Psoriatic Arthritis (PsA), A Pilot Study

Enrolling by invitation
  • Psoriatic Arthritis
    • La Jolla, California
    • +1 more
    Jun 22, 2023

    Psoriatic Arthritis Trial (Telemedicine)

    Not yet recruiting
    • Psoriatic Arthritis
    • Telemedicine
    • (no location specified)
    Dec 6, 2022

    HIPPOCRATES Prospective Observational Study

    Not yet recruiting
    • Psoriatic Arthritis
    • Psoriasis
    • PEST screening questionnaire
    • Oxford, Oxfordshire, United Kingdom
      Oxford University Hospital NHS Foundation Trust
    May 4, 2023

    PsA (Psoriatic Arthritis) Trial (Metformin)

    Not yet recruiting
    • PsA (Psoriatic Arthritis)
    • (no location specified)
    Aug 4, 2023

    Safety of Abatacept Treatment in Denmark Using Danish Database

    Active, not recruiting
    • Rheumatoid Arthritis (RA)
    • Psoriatic Arthritis (PsA)
      • Princeton, New Jersey
        Local Institution
      Jun 13, 2022

      Effectiveness of Advanced Therapies in Psoriatic Arthritis

      Recruiting
      • Psoriatic Arthritis
        • Toronto, Ontario, Canada
          Women's College Hospital
        Jul 20, 2023

        Oral Upadacitinib Tablets to Assess Adverse Events and Change in

        Recruiting
        • Rheumatoid Arthritis (RA)
        • +3 more
          • Bucheon, Gyeonggido, Korea, Republic of
          • +3 more
          Nov 8, 2022

          Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis Trial in Toulouse (Remsima IV, Remsima SC)

          Recruiting
          • Rheumatoid Arthritis
          • +3 more
          • Remsima IV
          • Remsima SC
          • Toulouse, France
            CHU Purpan Hôpital Pierre Paul Riquet
          May 17, 2023

          Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)

          Not yet recruiting
          • Psoriatic Arthritis
          • Philadelphia, Pennsylvania
            Hospital at the University of Pennsylvania
          Dec 20, 2022

          Psoriatic Arthritis Trial in Duncansville, South Charleston (Dose A VTX958, Dose B VTX958, Placebo)

          Recruiting
          • Psoriatic Arthritis
          • Dose A VTX958
          • +2 more
          • Duncansville, Pennsylvania
          • +1 more
          Feb 4, 2023

          Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)

          Not yet recruiting
          • Psoriatic Arthritis
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Nov 18, 2022

          Changes in Body Composition Under Ustekinumab in PsA

          Terminated
          • Psoriatic Arthritis
          • Bone mineral density (BMD)
          • Lille, France
            Hôpital Roger Salengro, CHU
          Oct 13, 2022

          Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With

          Completed
          Has Results
          • Psoriatic Arthritis
          • Baghdad, Iraq
            Pfizer
          Aug 17, 2021

          Psoriatic Arthritis, Foot Arthritis Trial in Sherbrooke (Custom foot orthoses)

          Completed
          • Psoriatic Arthritis
          • Foot Arthritis
          • Custom foot orthoses
          • Sherbrooke, Quebec, Canada
          • +1 more
          Sep 29, 2021

          Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)

          Completed
          • Psoriatic Arthritis
          • Frankfurt am Main, Hessia, Germany
            CIRI
          Mar 1, 2022

          Psoriatic Arthritis Trial in Philadelphia, Salt Lake City (Direct to patient PsA Screening Questionnaire)

          Recruiting
          • Psoriatic Arthritis
          • Direct to patient PsA Screening Questionnaire
          • Philadelphia, Pennsylvania
          • +1 more
          Jan 3, 2022

          Tofacitinib PsA Initiators in the CorEvitas SpA Registry

          Active, not recruiting
          • Psoriatic Arthritis
            • New York, New York
              Pfizer
            Feb 8, 2022

            DC-STAMP: Regulators of Osteoclastogenesis and Response Marker

            Completed
            • Psoriatic Arthritis
              • Rochester, New York
                University of Rochester Medical Center
              Aug 12, 2021

              Upadacitinib of Enthesitis Evaluated by Ultrasound in Psoriatic

              Not yet recruiting
              • Psoriatic Arthritis
              • Madrid, Spain
                Instituto de Investigación Sanitaria Fundación Jiménez Díaz
              Nov 25, 2023

              AsseSSing Impact in pSoriatic Treatment

              Recruiting
              • Psoriatic Arthritis
              • Questionnaire
              • Clermont-Ferrand, France
              • +20 more
              May 18, 2022

              UCB Cimzia Pregnancy Follow-up Study

              Terminated
              • Rheumatoid Arthritis (RA)
              • +3 more
                • Wilmington, North Carolina
                  Up0019 001
                Apr 19, 2021

                Evaluate Safety and Efficacy of Cosentyx in Pediatric PsV, PsA,

                Recruiting
                • Psoriasis Vulgaris
                • +2 more
                • Cosentyx
                • Nagoya-city, Aichi, Japan
                • +23 more
                Aug 3, 2022

                Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis

                Not yet recruiting
                • Psoriatic Arthritis
                  • (no location specified)
                  Nov 25, 2022

                  Psoriatic Arthritis Trial in United States (Izokibep, Placebo to izokibep)

                  Recruiting
                  • Psoriatic Arthritis
                  • Palm Desert, California
                  • +7 more
                  Jan 30, 2023

                  Psoriatic Arthritis Trial in Worldwide (AIN457 (secukinumab), Placebo)

                  Completed
                  Has Results
                  • Psoriatic Arthritis
                  • AIN457 (secukinumab)
                  • Placebo
                  • Beverly Hills, California
                  • +32 more
                  Nov 8, 2021